Welcome to Haas Healthcare and BioBusiness

The Haas Healthcare and BioBusiness Club (H2B2) is a student run organization based at the Haas School of Business that aims to both educate students on the multi-faceted nature of the healthcare and biotech industries as well as connect students with industry alumni and professionals. H2B2 was formed in early 2007 by the merger of two student organizations: Healthcare@Haas and the Berkeley BioBusiness Association. Our organization encompasses a comprehensive network of students, alumni, academicians and key professionals from across:

• the Haas School of Business

• the greater UC Berkeley community

• engineering, medical, public health, public policy, and law schools from the Bay Area

• the biotechnology, pharmaceutical, medical device and diagnostic industries

• provider organizations (hospitals & physician organizations), technology and health plans

• related service industries (consulting & investment banking)

Our network also includes:

• entrepreneurs

• venture capitalists

• other associations and business schools

This year we will launch several company treks, our annual Healthcare Firm Night, the HAAS HEALTHCARE CONFERENCE, the BioEntrepreneurship Roundtable And Venture Capital Forum as well as multiple speaker & social events.

Recent company treks include Genentech, McKesson, San Francisco General Hospital, Blue Shield of California, and Kaiser Permanente.

Recent participants of our annual Career Fair (A.K.A. Firm Night) include:

• Bio-Rad Laboratories

• Blue Shield of California

• Boston Scientific

• Chiron

• Deloitte Consulting

• Genentech

• GlaxoSmithKline

• Guidant

• Intel

• Johnson & Johnson

• Kaiser Permanente

• McKesson

• Medtronic

• ZS Associates

Our speakers series whose interests and backgrounds ranged from social responsibility in healthcare companies to universal healthcare. Each year, we organize a speaker series. Last year’s BioBusiness Speaker Series covered topics including: starting a med-device company, bringing biotech drugs to market, business development in bio-pharma, and strategic consulting to the life-sciences.  We are in the process of putting together another great line up of speakers for next fall’s series.